EXPERTISE
Life Sciences & Healthcare

Public consultation on the conditions, rules and procedure for regulating and registering prices of medicinal products in Bulgaria

December 2020 – Bulgaria’s Council of Ministers has opened public consultations on proposed amendments to the Ordinance on the conditions, rules and procedure for regulating and registering the prices of medicinal products in Bulgaria.

Peter Kováč leads online expert medical congress co-sponsored by Kinstellar Bratislava

December 2020 – Peter Kováč, Of Counsel and head of the Life Sciences & Healthcare practice in Kinstellar’s Bratislava office, served as lead organiser for the expert medical congress “Legal, Forensic and Economic Aspects of the Medical Profession”...

Updated guidance for clinical trials of medicinal products in Ukraine

October 2020 – On 28 September 2020, the State Expert Centre of the Ministry of Health of Ukraine ("the Centre") updated its non-binding guidance on the conduct of clinical trials of medicinal products, considering the current quarantine restrictions...

Life Sciences & Healthcare: Update on government measures in Kinstellar jurisdictions in response to the COVID-19 pandemic

1 July 2020 – The following is an overview of the current government measures concerning the life sciences and healthcare sectors in Bulgaria, the Czech Republic, Hungary, Kazakhstan, Romania, Serbia, Slovakia, Turkey and Ukraine. Please click here...

Kinstellar recognised as a leading law firm for Life Sciences with notable accolades, Eszter Takacsi-Nagy named Regulatory Rising Star at the LMG European Life Sciences Awards 2020

June 2020 – Kinstellar is delighted to be recognised at the LMG European Life Sciences Awards 2020 for its outstanding work across the industry. The annual awards are presented to firms, individuals and companies behind the most innovative and challenging...

Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Republic

June 2020 – Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group....

Life Sciences & Healthcare: Outlook and Opportunities

28 May 2020 – As companies continue to face the impact of the COVID-19 pandemic on their business, our experts keep you up to date and provide practical insights on the key developments related to your sector.

Medical cannabis: Proposed new cultivation and export rules for the Czech Republic

15 May 2020 – On 11 May 2020, the Czech government approved a bill amending the Act on Addictive Substances (the “Bill”). The purpose of the Bill is to expand the possibilities for cultivating cannabis for medical use to a broader range of subjects...

Slovakia: Updated summary of current COVID-19 extraordinary measures

9 April 2020 – It may be challenging for non-Slovak speakers to understand the recent stream of extraordinary measures imposed by the Slovak government in response to the COVID-19 pandemic, particularly if you are required to manage your businesses...

Czech Republic: Employment support program ANTIVIRUS

3 April 2020 – On 1 April 2020, the Government of the Czech Republic approved, via Resolution No. 353, a targeted employment support program called “Antivirus”. The aim of the Antivirus Program is to help businesses protect jobs by providing employers...